Free Trial
→ Make 22x more from this summer’s Bitcoin boom (From Brownstone Research) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIS
ProShares UltraShort Nasdaq Biotechnology
$17.87
-0.8%		$18.95
$14.05
▼
$25.87
$3.04M-1.4111,998 shs14,097 shs
CNCR
Range Cancer Therapeutics ETF
$9.32
-18.4%		$30.00
$7.88
▼
$16.27
$13.78M0.953,842 shs1,757 shs
JDOC
JPMorgan Healthcare Leaders ETF
$49.76
+0.2%		$50.01
$47.67
▼
$63.49
$7.46M0.61374 shs110 shs
TMED
T. Rowe Price Health Care ETF
$24.41
-0.1%		$0.00
$24.41
▼
$25.26
$3.00M-1.054,664 shs1,757 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIS
ProShares UltraShort Nasdaq Biotechnology
0.00%+4.99%-1.97%+3.96%+1.13%
CNCR
Range Cancer Therapeutics ETF
0.00%0.00%+4.84%-12.73%-31.72%
JDOC
JPMorgan Healthcare Leaders ETF
0.00%-1.11%+0.20%-7.56%-14.55%
TMED
T. Rowe Price Health Care ETF
0.00%-2.87%+2,440,999,900.00%+2,440,999,900.00%+2,440,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
N/AN/AN/AN/AN/AN/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/AN/AN/AN/AN/AN/AN/A
TMED
T. Rowe Price Health Care ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIS
ProShares UltraShort Nasdaq Biotechnology
0.00
N/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
0.00
N/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
2.74
Moderate Buy$49.76N/A
TMED
T. Rowe Price Health Care ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
N/AN/AN/AN/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/AN/AN/AN/AN/A
TMED
T. Rowe Price Health Care ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/A0.00∞N/AN/AN/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
N/AN/A0.00∞N/AN/AN/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/A25.23∞N/AN/AN/AN/AN/A
TMED
T. Rowe Price Health Care ETF
N/AN/A0.00∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIS
ProShares UltraShort Nasdaq Biotechnology
$0.653.64%N/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
$0.293.11%N/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
$2.815.65%N/AN/AN/A
TMED
T. Rowe Price Health Care ETF
N/AN/AN/AN/AN/A

Latest CNCR, JDOC, BIS, and TMED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/25/2025
BIS
ProShares UltraShort Nasdaq Biotechnology
Quarterly$0.13252.99%3/26/20253/26/20254/1/2025
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A
CNCR
Range Cancer Therapeutics ETF
N/A
JDOC
JPMorgan Healthcare Leaders ETF
N/A
TMED
T. Rowe Price Health Care ETF
N/A

Insider Ownership

CompanyInsider Ownership
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A
CNCR
Range Cancer Therapeutics ETF
N/A
JDOC
JPMorgan Healthcare Leaders ETF
N/A
TMED
T. Rowe Price Health Care ETF
11.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A170,000N/AOptionable
CNCR
Range Cancer Therapeutics ETF
N/A780,814N/ANot Optionable
JDOC
JPMorgan Healthcare Leaders ETF
N/A150,000N/AN/A
TMED
T. Rowe Price Health Care ETF
N/A123,000N/AN/A

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

ProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS

$17.87 -0.15 (-0.83%)
Closing price 06/18/2025 03:56 PM Eastern
Extended Trading
$17.86 -0.01 (-0.05%)
As of 06:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Range Cancer Therapeutics ETF NASDAQ:CNCR

The Loncar Cancer Immunotherapy ETF (CNCR) is an exchange-traded fund that is based on the Loncar Cancer Immunotherapy index. The fund tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs. CNCR was launched on Oct 13, 2015 and is managed by Loncar.

JPMorgan Healthcare Leaders ETF NASDAQ:JDOC

$49.76 +0.08 (+0.16%)
As of 06/18/2025 03:13 PM Eastern

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.

T. Rowe Price Health Care ETF NASDAQ:TMED

$24.41 -0.03 (-0.12%)
As of 06/18/2025 02:59 PM Eastern

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas